Patents by Inventor Saki SHINTO

Saki SHINTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES
    Publication number: 20230324358
    Abstract: The present invention provides: an assay method that uses a compound represented by formula (I) as a fluorescent probe molecule and that is for detecting the lipid peroxidation suppression activity of a test compound; an assay kit that uses the assay method; a screening method that uses the assay method; and a pharmaceutical composition that is for the treatment, etc. of diseases (such as age-related macular degeneration) that are induced by lipid peroxidation reactions.
    Type: Application
    Filed: November 2, 2022
    Publication date: October 12, 2023
    Inventors: Ken-ichi YAMADA, Saki SHINTO, Tomomi IDE, Keiichi YAMAMOTO
  • THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES
    Publication number: 20230324359
    Abstract: The present invention provides: an assay method that uses a compound represented by formula (I) as a fluorescent probe molecule and that is for detecting the lipid peroxidation suppression activity of a test compound; an assay kit that uses the assay method; a screening method that uses the assay method; and a pharmaceutical composition that is for the treatment, etc. of diseases (such as age-related macular degeneration) that are induced by lipid peroxidation reactions.
    Type: Application
    Filed: April 14, 2023
    Publication date: October 12, 2023
    Inventors: Ken-ichi YAMADA, Saki SHINTO, Tomomi IDE, Keiichi YAMAMOTO
  • Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
    Patent number: 11519893
    Abstract: The present invention provides: an assay method that uses a compound represented by formula (I) as a fluorescent probe molecule and that is for detecting the lipid peroxidation suppression activity of a test compound; an assay kit that uses the assay method; a screening method that uses the assay method; and a pharmaceutical composition that is for the treatment, etc. of diseases (such as age-related macular degeneration) that are induced by lipid peroxidation reactions.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: December 6, 2022
    Assignees: FUSO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Ken-ichi Yamada, Saki Shinto, Tomomi Ide, Keiichi Yamamoto
  • PHARMACEUTICAL COMPOSITION FOR INTRAOCULAR OR ORAL ADMINISTRATION FOR TREATMENT OF RETINAL DISEASES
    Publication number: 20220096410
    Abstract: The present invention may provide a pharmaceutical composition for intraocular administration or oral administration, for preventing or treating a retinal disease (such as age-related macular degeneration), or suppressing a progression of the disease in a subject in need of treatment, the composition comprising an effective amount of one or more compounds selected from the following group, and a pharmaceutically acceptable carrier; and a method therefor, a group consisting of apomorphine, eseroline, ethoxyquin, methyldopa, olanzapine and indapamide.
    Type: Application
    Filed: January 9, 2020
    Publication date: March 31, 2022
    Inventors: Ken-ichi YAMADA, Saki SHINTO, Minato ISHIDA, Keiichi YAMAMOTO
  • THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES
    Publication number: 20200158709
    Abstract: The present invention provides: an assay method that uses a compound represented by formula (I) as a fluorescent probe molecule and that is for detecting the lipid peroxidation suppression activity of a test compound; an assay kit that uses the assay method; a screening method that uses the assay method; and a pharmaceutical composition that is for the treatment, etc. of diseases (such as age-related macular degeneration) that are induced by lipid peroxidation reactions.
    Type: Application
    Filed: July 5, 2018
    Publication date: May 21, 2020
    Inventors: Ken-ichi YAMADA, Saki SHINTO, Tomomi IDE, Keiichi YAMAMOTO